Added to YB: 2024-03-18
Pitch date: 2024-03-17
PFE [bullish]
Pfizer Inc.
+9.3%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$155.6B
Pitch Price
$24.57
Price Target
41.00 (+53%)
Dividend
6.28%
EV/EBITDA
7.90
P/E
20.13
EV/Sales
3.24
Sector
Pharmaceuticals
Category
value
Show full summary:
Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns
PFE: Down 42% rev & 70% FCF YoY on Covid slump, but core +7%. $19-20B patents expiring is concern, but 31 P3 projects offer hope. Historically cheap at 12.4x EPS, 4.3x sales w/ 18% upside to $33-41 FV range + 6% yield. Risks: pipeline uncertainty, poor momentum.
Read full article (5 min)